Works matching DE "TRASTUZUMAB"

Results: 2929

A Reflection on the Evolution of Antibody‐Based Therapies in Oncology: Trastuzumab as an Exemplar—Commentary on Dijkers et al.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1577, doi. 10.1002/cpt.3651

By:

Holstein, Sarah A.

Publication type:

Article

Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1468, doi. 10.3390/cancers17091468

By:

Chen, Ping;
Zhang, Yu;
Bordeau, Brandon M.;
Balthasar, Joseph P.

Publication type:

Article

Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumab.

Published in:

Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00340-7

By:

Mammadova, Jamila;
Richards, Alicia;
Gonzalez-Torriente, Adriana;
Adler, Evan R.;
Cruz, Rachel J.;
Palfi, Stefanie;
Lee, Dae Hyun;
Sam, Christine;
Al-Jumayli, Mohammed;
Berglund, Anders;
Park, Jong Y;
Alomar, Mohammed;
Kresovich, Jacob K.

Publication type:

Article

Treatment patterns and associated outcomes among patients with HER2+ metastatic breast cancer in the United States: an observational cohort study.

Published in:

Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyae280

By:

Lam, Clara;
Varghese, Della;
Collins, Jenna;
Nordstrom, Beth;
Murphy, Brian;
Mehta, Sandhya;
Faherty, Eleanor

Publication type:

Article

Post-marketing safety surveillance of ado-trastuzumab emtansine: a real-world data retrospective cohort study using disproportionality analysis.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 5, p. 565, doi. 10.1080/14740338.2024.2438748

By:

Chen, Endong;
Gan, Yaowei;
Chen, Yingying;
Chen, Chen;
Weng, Yujing;
Zhang, Bowen;
Cai, Yefeng;
Wang, Qingxuan;
Li, Quan

Publication type:

Article

Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.

Published in:

Indian Journal of Pharmacology, 2016, v. 48, n. 5, p. 490, doi. 10.4103/0253-7613.190719

By:

Rygiel, Katarzyna

Publication type:

Article

Dilated cardiomyopathy following trastuzumab chemotherapy.

Published in:

2012

By:

Karmakar, Saurabh;
Dixit, Rakesh;
Nath, Alok;
Kumar, Santosh;
Karmakar, Shilpi

Publication type:

Case Study

Promising molecular targeted therapies in breast cancer.

Published in:

Indian Journal of Pharmacology, 2011, v. 43, n. 3, p. 236, doi. 10.4103/0253-7613.81497

By:

Munagala, Radha;
Aqil, Farrukh;
Gupta, Ramesh C.

Publication type:

Article

Trastuzumab.

Published in:

Indian Journal of Pharmacology, 2004, v. 36, n. 6, p. 390

By:

Beedimani, R. S.

Publication type:

Article

Current Perspectives on HER2 Testing: A Review of National Testing Guidelines.

Published in:

Modern Pathology, 2003, v. 16, n. 2, p. 173, doi. 10.1097/01.MP.0000052102.90815.82

By:

Bilous, Michael;
Dowsett, Mitch;
Hanna, Wedad;
Isola, Jorma;
Lebeau, Annette;
Moreno, Aberlardo;
Penault-Llorca, Frédérique;
Rüschoff, Josef;
Tomasic, Gorana;
Van de Vijver, Marc

Publication type:

Article

Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer.

Published in:

2016

By:

Gijsen, Merel;
King, Peter;
Perera, Tim;
Parker, Peter J.;
Harris, Adrian L.;
Larijani, Banafshé;
Kong, Anthony

Publication type:

Correction Notice

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer.

Published in:

PLoS Biology, 2010, v. 8, n. 12, p. 1, doi. 10.1371/journal.pbio.1000563

By:

Gijsen, Merel;
King, Peter;
Perera, Tim;
Parker, Peter J.;
Harris, Adrian L.;
Larijani, Banafshé;
Kong, Anthony

Publication type:

Article

A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2011, v. 51, n. 4, p. 372, doi. 10.1111/j.1479-828X.2011.01314.x

By:

MANDRAWA, Christine L.;
STEWART, Josephine;
FABINYI, Gavin C.;
WALKER, Susan P.

Publication type:

Article

Radiolabelled <sup>177</sup>Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers.

Published in:

Chemistry - A European Journal, 2024, v. 30, n. 14, p. 1, doi. 10.1002/chem.202303805

By:

Cieslik, Patrick A.;
Klingler, Simon;
Nolff, Mirja;
Holland, Jason P.

Publication type:

Article

Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 11, p. 1, doi. 10.1002/chem.202202491

By:

Hashad, Rania A.;
Jap, Edwina;
Casey, Joanne L.;
Candace Ho, Y. T.;
Wright, Alexander;
Thalmann, Claudia;
Sleeman, Mark;
Lupton, David W.;
Hagemeyer, Christoph E.;
Cryle, Max J.;
Robert, Remy;
Alt, Karen

Publication type:

Article

Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 269, doi. 10.1007/s00280-009-1160-0

By:

Fujimoto-Ouchi, Kaori;
Sekiguchi, Fumiko;
Yamamoto, Kaname;
Shirane, Masatoshi;
Yamashita, Yoriko;
Mori, Kazushige

Publication type:

Article

In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 697, doi. 10.1007/s00280-009-1075-9

By:

Ozbay, Tuba;
Durden, Donald L.;
Tongrui Liu;
O'Regan, Ruth M.;
Nahta, Rita

Publication type:

Article

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8

By:

Ishida, Takanori;
Kiba, Takayoshi;
Takeda, Motohiro;
Matsuyama, Kotone;
Teramukai, Satoshi;
Ishiwata, Ryota;
Masuda, Norikazu;
Takatsuka, Yuichi;
Noguchi, Shinzaburo;
Ishioka, Chikashi;
Fukushima, Masanori;
Ohuchi, Noriaki

Publication type:

Article

Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 2, p. 275, doi. 10.1007/s00280-008-0737-3

By:

Montagna, E.;
Cancello, G.;
D’Agostino, D.;
Lauria, R.;
Forestieri, V.;
Esposito, A.;
Silvestro, L.;
Accurso, A.;
De Placido, S.;
De Laurentiis, M.

Publication type:

Article

Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1085, doi. 10.1007/s00280-008-0709-7

By:

Ruiz, M.;
Salvador, J.;
Bayo, J.;
Lomas, M.;
Moreno, A.;
Valero, M.;
Bernabé, R.;
Vicente, D.;
Jiménez, J.;
Lopez-Ladrón, A.

Publication type:

Article

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 159, doi. 10.1007/s00280-007-0586-5

By:

Osako, Tomo;
Ito, Yoshinori;
Takahashi, Shunji;
Tokudome, Nahomi;
Iwase, Takuji;
Hatake, Kiyohiko

Publication type:

Article

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 509, doi. 10.1007/s00280-007-0497-5

By:

Yamamoto, Daigo;
Iwase, Satoru;
Kitamura, Kaoru;
Odagiri, Hiroki;
Yamamoto, Chizuko;
Nagumo, Yoshinori

Publication type:

Article

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 6, p. 795, doi. 10.1007/s00280-006-0337-z

By:

Fujimoto-Ouchi, Kaori;
Sekiguchi, Fumiko;
Yasuno, Hideyuki;
Moriya, Yoichiro;
Mori, Kazushige;
Tanaka, Yutaka

Publication type:

Article

Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 554, doi. 10.1007/s00280-005-0092-6

By:

Bartsch, Rupert;
Wenzel, Catharina;
Pluschnig, Ursula;
Hussian, Dagmar;
Sevelda, Ursula;
Locker, Gottfried J.;
Mader, Robert;
Zielinski, Christoph C.;
Steger, Guenther G.

Publication type:

Article

Trastuzumab: updates and future issues.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 94, doi. 10.1007/s00280-005-0110-8

By:

Toi, Masakazu;
Horiguchi, Kazumi;
Bando, Hiroko;
Saji, Shigehira;
Chow, Louis W. C.

Publication type:

Article

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 361, doi. 10.1007/s00280-005-1026-z

By:

Bruno, Rene;
Washington, Carla B.;
Jian-Feng Lu;
Lieberman, Grazyna;
Banken, Ludger;
Klein, Pamela

Publication type:

Article

In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 2, p. 186, doi. 10.1007/s00280-003-0728-3

By:

Nahta, Rita;
Esteva, Francisco J.

Publication type:

Article

Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5′-dFUrd in human breast cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 211, doi. 10.1007/s00280-001-0401-7

By:

Fujimoto-Ouchi, Kaori;
Sekiguchi, Fumiko;
Tanaka, Yutaka

Publication type:

Article

Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 160, doi. 10.1159/000333396

By:

Huober, Jens;
Baumann, Michael;
Rochlitz, Christoph;
Aebi, Stefan;
Güth, Uwe;
von Moos, Roger;
Müller, Andreas;
von Rohr, Lukas;
Widmer, Isabelle;
Thürlimann, Beat

Publication type:

Article

Clinical Significance of PTEN and p-Akt Co-Expression in HER2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab-Based Therapies.

Published in:

Oncology, 2010, v. 78, n. 2, p. 141, doi. 10.1159/000312656

By:

Fabi, A.;
Metro, G.;
Di Benedetto, A.;
Nisticò, C.;
Vici, P.;
Melucci, E.;
Antoniani, B.;
Perracchio, L.;
Sperduti, I.;
Milella, M.;
Cognetti, F.;
Mottolese, M.

Publication type:

Article

Targeted HER2 Treatment in Advanced Gastric Cancer.

Published in:

Oncology, 2010, v. 78, n. 1, p. 26, doi. 10.1159/000288295

By:

Jørgensen, Jan Trøst

Publication type:

Article

Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer.

Published in:

Oncology, 2009, v. 77, p. 14, doi. 10.1159/000258491

By:

Clavarezza, Matteo;
Venturini, Marco

Publication type:

Article

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer.

Published in:

Oncology, 2009, v. 76, n. 4, p. 275, doi. 10.1159/000207504

By:

Christodoulou, Christos;
Kostopoulos, Ioannis;
Kalofonos, Haralabos P.;
Lianos, Evangelos;
Bobos, Mattheos;
Briasoulis, Evangelos;
Gogas, Helen;
Razis, Evangelia;
Skarlos, Dimosthenis V.;
Fountzilas, George

Publication type:

Article

Targeting Her-2/neu in Breast Cancer: As Easy as This!

Published in:

Oncology, 2008, v. 74, n. 3/4, p. 150, doi. 10.1159/000151362

By:

Azim, Hamdy;
Azim Jr., Hatem A.

Publication type:

Article

Vascular Endothelial Growth Factor Partially Inhibits the Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity of Human Monocytes.

Published in:

Oncology, 2007, v. 72, n. 3/4, p. 172, doi. 10.1159/000112803

By:

Mimura, Kousaku;
Kono, Koji;
Takahashi, Akihiro;
Kawaguchi, Yoshihiko;
Mizukami, Yoshiki;
Fujii, Hideki

Publication type:

Article

A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer.

Published in:

Oncology, 2004, v. 66, n. 1, p. 38, doi. 10.1159/000076333

By:

Montemurro, Filippo;
Choa, Gabriella;
Faggiuolo, Roberto;
Donadio, Michela;
Minischetti, Monica;
Durando, Antonio;
Capaldi, Antonio;
Vietti-Ramus, Guido;
Alabiso, Oscar;
Aglietta, Massimo

Publication type:

Article

Perspectives on Anti-HER Monoclonal Antibodies.

Published in:

Oncology, 2002, v. 63, p. 17, doi. 10.1159/000066203

By:

Ranson, Malcolm;
Sliwkowski, Mark X.

Publication type:

Article

Current Status of HER2 Testing.

Published in:

Oncology, 2002, v. 63, p. 25, doi. 10.1159/000066204

By:

Di Leo, Angelo;
Dowsett, Mitch;
Horten, Bruce;
Penault-Llorca, Frédérique

Publication type:

Article

What Can We Learn from Herceptin[sup ®] Trials in Metastatic Breast Cancer?

Published in:

Oncology, 2002, v. 63, p. 39, doi. 10.1159/000066200

By:

Bell, Richard

Publication type:

Article

The Future of Targeted Therapy: Combining Novel Agents.

Published in:

Oncology, 2002, v. 63, p. 47, doi. 10.1159/000066197

By:

Gianni, Luca

Publication type:

Article

Moving Forward: Herceptin[sup ®] in the Adjuvant Setting.

Published in:

Oncology, 2002, v. 63, p. 57, doi. 10.1159/000066201

By:

Tan-Chiu, Elizabeth;
Piccart, Martine

Publication type:

Article

Effectiveness of Trastuzumab (Herceptin[sup TM] ) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment.

Published in:

Oncology, 2001, v. 61, n. 4, p. 271, doi. 10.1159/000055333

By:

Gerber, Bernd;
Krause, Annette;
Markmann, Susanne;
Reimer, Toralf;
Fietkau, Rainer;
Müller, Heiner

Publication type:

Article

Herceptin[sup ®] Alone or in Combination with Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Pivotal Trials.

Published in:

Oncology, 2001, v. 61, p. 14, doi. 10.1159/000055397

By:

Baselga, José

Publication type:

Article

Title Page / Contents / Preface.

Published in:

Oncology, 2001, v. 61, p. I, doi. 10.1159/000055395

By:

Khayat, David

Publication type:

Article

Biology of HER2 and Its Importance in Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 1, doi. 10.1159/000055396

By:

Yarden, Yosef

Publication type:

Article

Dose Scheduling – Herceptin[sup ®].

Published in:

Oncology, 2001, v. 61, p. 31, doi. 10.1159/000055399

By:

Leyland-Jones, Brian

Publication type:

Article

First-Line Herceptin[sup ®] Monotherapy in Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 37, doi. 10.1159/000055400

By:

Vogel, Charles L.;
Cobleigh, Melody A.;
Tripathy, Debu;
Gutheil, John C.;
Harris, Lyndsay N.;
Fehrenbacher, Louis;
Slamon, Dennis J.;
Murphy, Maureen;
Novotny, William F.;
Burchmore, Michael;
Shak, Steven;
Stewart, Stanford J.

Publication type:

Article

Interaction between Herceptin[sup ®] and Taxanes.

Published in:

Oncology, 2001, v. 61, p. 43, doi. 10.1159/000055401

By:

Diéras, Véronique;
Beuzeboc;
Laurence;
Pierga;
Pouillart

Publication type:

Article

New Combinations with Herceptin[sup ®] in Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 50, doi. 10.1159/000055402

By:

Winer, Eric P.;
Burstein, Harold J.

Publication type:

Article

Retrospective Analysis of the Safety of Herceptin[sup ®] Immunotherapy in Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 58, doi. 10.1159/000055403

By:

Cook-Bruns, Nancy

Publication type:

Article